Latest News - Stryker Corporation
Top Corporates Hub
Stryker Corporation
Stryker (SYK) Reports Q3: Everything You Need To Know Ahead Of Earnings
29.10.2025 03:10
Medical technology company Stryker (NYSE:SYK) will be reporting results this Thursday afternoon. Here’s what investors should know.
What Analyst Projections for Key Metrics Reveal About Stryker (SYK) Q3 Earnings
27.10.2025 13:15
Beyond analysts' top-and-bottom-line estimates for Stryker (SYK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
Buy 3 Wide Moat Stocks to Enhance Your Portfolio Returns in Q4
21.10.2025 13:16
MCO, SYK and CBRE stand out as wide moat stocks with strong growth forecasts and strategic expansions to boost portfolio resilience.
Orthopedic Digit Implants Market Report 2025-2033, with Profiles of Extremity Medical, Stryker, Zimmer, Smith & Nephew, Depuy, Arthrex, Acumed, Anika Therapeutics, VILEX, and Paragon 28
08.10.2025 08:26
Key opportunities in the orthopedic digit implants market include rising demand due to increasing prevalence of arthritis, technological advancements in biomaterials and implant design, and strategic partnerships among industry players. Additionally, growing preference for minimally invasive procedures and new market entrants offer significant potential. Orthopedic Digit Implants Market Orthopedic Digit Implants Market Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "Orthopedic Digit Implants Mark
Stryker, Siemens Healthineers partner on neurovascular robot
17.09.2025 12:16
The companies will develop a robotic system to improve patient outcomes in complex hemorrhagic cases and time-sensitive ischemic strokes.
Knee Replacement Surgeries Industry Report 2025-2030 - Osteoarthritis & Rheumatoid Arthritis Led Applications in 2024
02.09.2025 10:14
Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Knee Replacement Surgery Market by Procedure Type (Knee Replacement: Total, Partial, Revision), Product (Implants: Hybrid, Plastic, Metal or Ceramic; Orthobiologic, Braces), Application (Arthritis, Cancer), End User (Clinics, ASCs) - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The global knee replacement surgery market is anticipated to grow from USD 12.00 billion in 2025 to USD 16.17 billion by 2030, registering a
How Investors May Respond To Stryker (SYK) Raising 2025 Guidance on Robotics and Innovation Momentum
27.08.2025 10:08
Stryker Corporation recently announced strong second-quarter 2025 results, highlighting robust momentum in its orthopaedics, MedSurg, and Neurotechnology businesses, driven by increased robotics adoption and ongoing innovation. Management’s decision to raise full-year sales and adjusted earnings guidance reflects growing confidence in the company’s product pipeline and resilience against industry headwinds and competitive pressures. Next, we'll explore how Stryker's upgraded guidance and...
Stryker: Strong Multi-Faceted Growth Continuing To Support The Shares
19.08.2025 13:50
Stryker continues to outperform peers with strong revenue growth, margin expansion, and successful product innovation. Learn more on SYK stock here.
Medtronic says will add two independent directors after Elliott takes large stake
19.08.2025 09:59
Medtronic said on Tuesday it would add two new directors to its board and form new committees after Elliott Investment Management became one of its largest shareholders. Shares of the medical-device maker gained 2.4% in premarket trading and the stock has risen more than 16% so far this year. The company will add veteran med-tech executives John Groetelaars and Bill Jellison as independent directors, Medtronic said.
Stryker to participate in the 2025 Wells Fargo Securities Healthcare Conference
14.08.2025 12:00
Portage, Michigan, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2025 Wells Fargo Securities Healthcare Conference on Thursday, September 4, at the Encore Boston Harbor. Andy Pierce, Group President, MedSurg and Neurotechnology, and Jason Beach, Vice President, Finance and Investor Relations will participate in a Fireside Chat scheduled for 2:15 pm Eastern Time. A live audio webcast of the session, along with a replay, will be accessible on Stryker’s official websi
Orthopedic Devices Company Evaluation Report 2024-2025 | Stryker, Zimmer Biomet, and Johnson & Johnson MedTech Lead Across Joint Replacement, Trauma, and Surgical Solutions
13.08.2025 10:27
The Orthopedic Devices Companies Quadrant provides in-depth analysis of the global orthopedic devices market, spotlighting key players and industry trends. According to MarketsandMarkets 360 Quadrants, the top 14 orthopedic device companies have been identified as quadrant leaders. Driven by an aging population and rising orthopedic conditions, this market is growing steadily. Key innovations like orthobiologics, robotic surgeries, and 3D printing are creating new opportunities. Major companies
SYK Q2 Deep Dive: Tariffs, Supply Chain, and Robotics Weigh on Market Sentiment
13.08.2025 03:50
Medical technology company Stryker (NYSE:SYK) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 11.1% year on year to $6.02 billion. Its non-GAAP profit of $3.13 per share was 1.9% above analysts’ consensus estimates.
5 Revealing Analyst Questions From Stryker’s Q2 Earnings Call
13.08.2025 03:39
Stryker’s second quarter results were met with a negative market reaction, despite the company surpassing Wall Street’s revenue and profit expectations. Management described robust demand across its core product portfolio, particularly highlighting double-digit growth in MedSurg and Neurotechnology and solid performance in orthopedics. CEO Kevin Lobo pointed to strong U.S. momentum, driven by procedural volume growth, expanding adoption of robotic-assisted surgery, and healthy hospital capital s
Stereotactic Neuro-Navigation System Market Analysis Report 2025-2035 | Partnerships and Innovations Drive Progress in Technologies, Spinal Applications Lead Amid Rise in Spinal Disorders
11.08.2025 09:29
The global stereotactic neuro-navigation system market is anticipated to experience significant growth, escalating from a valuation of $840.7 million in 2024 to $3.10 billion by 2035, with a CAGR of 12.92%. This burgeoning demand is driven by the increasing incidence of neurological disorders, a shift towards minimally invasive surgeries, and technological advancements, including AI and augmented reality, which enhance surgical precision. Key industry players such as Medtronic, Brainlab, and Str
Stryker's (NYSE:SYK) Soft Earnings Don't Show The Whole Picture
08.08.2025 12:52
NYSE:SYK 1 Year Share Price vs Fair Value Explore Stryker's Fair Values from the Community and select yours The most...
Stryker (SYK): Buy, Sell, or Hold Post Q2 Earnings?
08.08.2025 04:03
Since February 2025, Stryker has been in a holding pattern, posting a small loss of 3.8% while floating around $377.49. The stock also fell short of the S&P 500’s 4.5% gain during that period.